Bladder Cancer and Urinary Schistosomiasis in Angola

 

 

Monica C. Botelho, Jacinta Figueiredo, Helena Alves

 

 

Monica C. Botelho, Helena Alves, INSA, National Institute of Health Dr. Ricardo Jorge, Rua Alexandre Herculano, 321, 4000-055 Porto, Portugal

Monica C. Botelho, IPATIMUP, Institute of Pathology and Molecular Immunology of the University of Porto, Portugal

Jacinta Figueiredo, Department of Urology, Hospital Americo Boavida, Luanda, Angola

Correspondence to: Monica C. Botelho, INSA, National Institute of Health Dr. Ricardo Jorge, Rua Alexandre Herculano, 321, 4000-055 Porto, Portugal

Email: monicabotelho@hotmail.com

Telephone: +351-223401114

Received: March 30, 2015              Revised: May 22, 2015

Accepted: May 26, 2015

Published online: June 26, 2015

 

ABSTRACT

Schistosomiasis haematobia is among the most prevalent parasitosis in Angola. The pathology is characterized by serious and irreversible lesions in the urogenital tract induced by chronic infection with the parasite that can eventually lead to squamous cell carcinoma of the bladder. Considering the frequency and severe morbidity observed, even in younger ages, the purpose of this study was to assess the prevalence and morbidity of S. haematobium infection in Angola. A baseline survey was conducted between November 2007 and February 2008. A randomly sample of 300 inhabitants aged 15 to 75 years old participated in this study. Prevalence of S. haematobium infection was 71.7 % (215/300). Infection was higher in females (56.3 %) but no significant difference was found in prevalence and intensity between gender and age groups. The predominant self-reported symptoms were dysuria (91.2 %), hypogastralgia (88.7 %) and haematuria (87.1%) and these symptoms were strongly associated with S. haematobium infection (p<0.05). Ultrasound and cystoscopy examinations performed in a sub-sample of 29 individuals revealed pathological conditions at the urinary tract in all examined. Considering the high prevalence of S. haematobium infections in Angola and schistosomiasis-associated bladder cancer, our results indicate that this population should be targeted for follow-up and implementation of measures for treatment and control of schistosomiasis.

 

© 2015 ACT. All rights reserved.

 

Key words: Schistosomiasis haematobia; Urogenital schistosomiasis; Squamous cell carcinoma of the bladder; Angola

 

Botelho MC, Figueiredo J, Alves H. Bladder Cancer and Urinary Schistosomiasis in Angola. Journal of Nephrology Research 2015; 1(1): 22-24 Available from: URL: http://www.ghrnet.org/index.php/jnr/article/view/1138

 

EDITORIal

Schistosomiasis is an endemic disease in 76 countries of America, Africa and Asia. According to World Health Organization (WHO)[1], this disease affects 200 to 300 million people and 650 millions are estimated to be at risk of infection. In some countries transmission of this disease was interrupted namely Portugal, Cyprus, Tunisia, Israel and Japan[2], but the risk of re-introduction persists as recently observed in Corsica, France[3].

    In the case of S. haematobium 120 millions show urinary symptoms, of which 70 millions have haematuria, 18 millions morphological alterations of the vesical wall[4] and 10-40 millions have obstructive uropathy[5]. Lesions in urinary tract caused by S. haematobium in sub-Saharan Africa are characterized by signs and symptoms like haematuria, dysuria and hipogastralgy, and in advanced stages can evolve to cancer[6,7]. Ultrasound analysis permits the detection of alterations of urinary tract, kidneys (hydronephrosis), as well as lesions and presence of “sandy patches” in the vesical wall[1,8,9].

    Angola is situated in the western part of Western Africa. It occupies a territory of 1,246,700 Km2. Its political frontiers are north Republic of Congo, south Namibia, east Republic of Zambia and Democratic Republic of Congo (ex-Zaire) and west the Atlantic Ocean. The territory is divided in 18 provinces: Bengo, Benguela, Bié, Cabinda, Kunene, Huambo, Huíla, Kwanza Norte, Kwanza South, Kwando Kubango, Luanda, Lunda North, Lunda South, Malange, Moxico, Namibe, Uíge and Zaire. In 2007 the population was estimated in 12,263,600 inhabitants. Angola has 5 major rivers: Kwanza, Kunene, Kubango, Cuvo and Bengo. Like other water born diseases, deficient sewerage and water treatment, as well as population education, are the main causes of schistosomiasis which is characterized as a neglected disease.

    Given the increase in the migratory flux of the rural population to urban areas, and the degradation of socio-economic conditions in the last years, the consequences of this infection are underestimated.

    Our study addressed S. haematobium infection in a population of 300 individuals aged 15-75 years in Angola. This is the first report involving such a wide region in this country where we have obtained an appalling prevalence of 71.7% (215/300). This region should be considered hiperendemic in as much as its prevalence of schistosomiasis is above the 50 % threshold determined by WHO[9].

    The infection pattern in the study population is normal in males showing a decrease in prevalence and intensity of infection with age. This is explained by the reduction of exposure to contaminated water[10]. On the contrary females, besides being more infected, presented a pattern of infection highest in the intermediate age group (25-34). This reflects an association between reproductive age and higher exposure to contaminated water due to domestic activities.

    This study proved that in the rural environment, agriculture is the main source of subsistence and also the main activity responsible for exposure to S. haematobium infection in both gender, followed by domestic activity affecting only females.

    Haematuria, dysuria and hypogastralgia are signs and symptoms of the acute phase of schistosomiasis and easily percepted by infected individuals. Therefore they are of great value to alert health authorities in endemic areas of S. haematobium[11]. In our report dysuria (91.2%), hypogastralgia (88.7%) and haematuria (74%) were the most frequent complaints by the participants and they were significantly associated with infection.

    Twenty nine (9.7%) individuals with ages ranging between 25 and 34 years were selected for ultrasonographic analysis because of the severity of their complaints. All of them exhibited thickening of the vesical wall. This is due to the aggressiveness of eggs deposited in the venules of the bladder, leading to decreased volume of the bladder and later to vesico-ureteral reflux and hydronephrosis[11,12]. Here hydronephrosis was identified in 7 (24.1%) cases.

    Cystoscopy confirmed the lesions from ultrasonography as well as allowed to evaluate the extension of lesions. This exam indentified granulomas in 13 cases (44.8%), calcifications of the bladder wall in 3 cases (10.3%) and 1 vesical tumor (3.4%). This tumor was classified as squamous cell carcinoma (SCC). The low frequency of tumors found in our series is in agreement with other authors who reported that the incidence of SCC is 3-4/100 000 cases[7].

    Histopathological exam of biopsies confirmed the lesions in which were predominantly granulomas with calcified eggs (72.4%). Presence of these lesions in younger ages (15-24 years) were 17.2%. This is in agreement with other reports[12].

    The alterations detected by ultrasonography and cystoscopy allowed the detection and grading of the lesions in the urogenital tract of 29 patients. Given the significantly elevated prevalence of vesical schistosomiasis in Angola, these exams should be mandatory in all cases with severe symptoms.

    Future studies should be developed for non-invasive, indirect tests to detect precursor lesions of bladder cancer. Our group has been developing such methodology with the use of biomarkers specific of S. haematobium[13,14]. We have previously described estrogen metabolites to be associated with schistosomiasis infected persons[15-18]. These metabolites can be expected to provide deeper insights into the carcinogenesis of urinary schistosomiasis-induced bladder cancer, and as biomarkers for diagnosis and/or prognosis of this neglected tropical disease-associated cancer.

 

CONFLICT OF INTERESTS 

The authors declare no conflict of interest.

 

REFERENCES

1.  WHO. Division of control of tropical diseases schistosomiasis, Bull World Health Organ Geneva, 2006.

2.   Botelho MC, Machado JC, Brindley PJ, Correia da Costa JM. Targeting molecular signaling pathways of Schistosoma haemotobium infection in bladder cancer. Virulence. 2011; 2: 267-79.

3.  Holtfreter MC, Moné H, Müller-Stöver i, Mouahid G, Richter J. Schistosoma haematobium infections acquired in Corsica, France, August 2013. Eurosurveillance, 2014; 19.

4.   Van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, Habbema JD, Engels D. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 2003; 86: 125-39.

5.   WHO. Guidelines for the evaluation of soil-transmitted helminthiasis and schistosomiasis at community level. Bull World Health Organization. Geneva. 1998; 53.

6.   Van Le TS, Myers J, Konety BR, Barder T, Getzenberg RH. Functional characterization of the bladder cancer marker, BLCA-4. Clin Cancer Res. 2004; 10: 1384-91.

7.   Shiff C, Veltri R, Naples J, Quartey J, Otchere J, Anyan W, Marlow C, Wiredu E, Adjei A, Brakohiapa E, Bosompem K. Ultrasound verification of bladder damage is associated with known biomarkers of bladder cancer in adults chronically infected with Schistosoma haematobium in Ghana. Trans R Soc Trop Med Hyg. 2006; 100: 847-54.

8.   WHO. Expert Committee on the Control of Schistosomiasis. Public health impact of schistosomiasis disease and mortality. Bull World Health Organization. Geneva, 2003; 71: 657-662.

9.   WHO. Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. Bull World Health Organization, Geneva, 2002.

10.  Okoli CG, Iwuala MO. The prevalence, intensity and clinical signs of urinary schistosomiasis in Imo state, Nigeria. J Helminthol. 2004, 78: 337-42.

11.  King CH, Keating CE, Muruka JF, Ouma JH, Houser H, Siongok TK, Mahmoud AA. Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province, Kenya. Am J Trop Med Hyg, 1988; 39: 361-8.

12.  Abdel-Wahab MF, Ramzy I, Esmat G, el Kafass H, Strickland GT. Ultrasound for detecting Schistosoma haematobium urinary tract complications: comparison with radiographic procedures. J Urol, 1992; 148: 346-50.

13.  Botelho MC, Soares R, Vale N, Ribeiro R, Camilo V, Almeida R, Medeiros R, Gomes P, Machado JC, Correia da Costa JM. Schistosoma haematobium: identification of new estrogenic molecules with estradiol antagonistic activity and ability to inactivate estrogen receptor in mammalian cells. Exp Parasitol. 2010; 126: 526-35.

14.  Botelho MC, Ribeiro R, Vale N, Oliveira P, Medeiros R, Lopes C, Machado JC, Correia da Costa JM. Inactivation of estrogen receptor by Schistosoma haematobium total antigen in bladder urothelial cells. Oncol Rep. 2012; 27: 356-62.

15.  Botelho MC, Vale N, Gouveia MJ, Rinaldi G, Santos J, Santos LL, Gomes P, Brindley PJ, Correia da Costa JM. Tumour-like phenotypes in urothelial cells after exposure to antigens from eggs of Schistosoma haematobium: an oestrogen-DNA adducts mediated pathway? Int J Parasitol. 2013; 43: 17-26.

16.  Santos J, Gouveia MJ, Vale N, Delgado Mde L, Gonçalves A, da Silva JM, Oliveira C, Xavier P, Gomes P, Santos LL, Lopes C, Barros A, Rinaldi G, Brindley PJ, da Costa JM, Sousa M, Botelho MC. Urinary estrogen metabolites and self-reported infertility in women infected with Schistosoma haematobium. PLoS One. 2014; 9: e96774. doi: 10.1371/journal.pone.0096774.

17.  Botelho MC, Sousa M. New biomarkers to fight urogenital schistosomiasis: a major neglected tropical disease. Biomark Med. 2014; 8: 1061-3. doi: 10.2217/bmm.14.68.

18.  Botelho MC, Alves H, Barros A, Rinaldi G, Brindley PJ, Sousa M. The role of estrogens and estrogen receptor signaling pathways in cancer and infertility: the case of schistosomes. Trends Parasitol. 2015; doi: 10.1016/j.pt.2015.03.005.

 

Peer reviewers: Sakip Erturhan, Professor, MD, Gaziantep University, Faculty of Medicine, Department of Urology, 27310, Şahinbey / Gaziantep , Turkey, Draga Ivanova Toncheva, Professor, Department of Medical Genetics, Medical University-Sofia, “Zdrave” 2 str., 1431 Sofia, Bulgaria.

 

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.